CEACAM1 and breast cancer: In these candidate gene sets, CEACAM1 expression is reduced or lost in breast cancer compared to normal tissues and controls the switch of epithelial-to-mesenchymal transition (EMT), which is involved in endocrine resistance [31,32,33,34].